Satellos Bioscience earnings were N/A for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MSLE earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$5.6M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MSLE reported annual earnings of -$28.1M, with 76.8% growth.
MSLE earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
MSLE Return on Equity
Insufficient data to display
MSLE Return on Assets
Insufficient data to display
Be the first to know when MSLE announces earnings.
Satellos Bioscience Earnings Reports & History FAQ
What were Satellos Bioscience's earnings last quarter?
Satellos Bioscience (NASDAQ: MSLE) reported Q2 2025 earnings per share (EPS) of -$0.36, up 25% year over year. Total MSLE earnings for the quarter were -$5.61 million. In the same quarter last year, Satellos Bioscience's earnings per share (EPS) was -$0.48.
Is Satellos Bioscience profitable or losing money?
As of the last Satellos Bioscience earnings report, Satellos Bioscience is currently losing money. Satellos Bioscience's net profit (also called net income) for the twelve months ending Jun 30, 2025 was N/A, a N/A decrease year over year.
What was MSLE's earnings growth in the past year?
As of Satellos Bioscience's earnings date in Q1 2026, Satellos Bioscience's earnings has grown year over year. MSLE earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.